First pharmacokinetic-pharmacodynamic study in humans with a selective 5-hydroxytryptamine4 receptor agonist

Journal of Clinical Pharmacology

Volumn 37, Issue 3, 1997, Pages 229-237

  Appel, Silke ^a   Kumle, Anette ^a   Hubert, Martine ^b   Duvauchelle, Thierry ^c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Laboratoire Novartis   (France)

^c Aster   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHOXYINDOL 3 CARBOXALDEHYDE AMINO(PENTYLAMINO)METHYLENEHYDRAZONE HYDROGENMALEATE; PLACEBO; PROKINETIC AGENT; SEROTONIN 4 AGONIST; TEGASEROD; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; COLON MOTILITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG SELECTIVITY; DRUG TOLERABILITY; FLATULENCE; GASTROINTESTINAL MOTILITY; HEADACHE; HUMAN; HUMAN EXPERIMENT; INTESTINE TRANSIT TIME; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0030893442     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb04785.x     Document Type: Article

References (40)

1. Talley NJ: Review: 5-hydroxytryptamine agonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Phannacol Ther 1992;6:273-289.
2. Saxena PR: Serotonin receptors: Subtypes, functional responses and therapeutic relevance. Pharmacol Ther 1995;66:339-368.
3. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al: The IUPHAR classification of receptors of 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
4. Martin GR, Humphrey PPA: Classification review. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology 1994;33:261-273.
5. 4 receptor coupled to adenylyl cyclase stimulation in human brain. Life Sci 1993;52:61-65.
6. Craig DA, Clarke DE: Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor. J Pharmacol Exp Ther 1990;252:1378-1386.
7. 4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn Schmiedebergs Arch Pharmacol 1991;343:439-446.
8. Reeves JJ, Bunce KT, Humphrey PAA: Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus. Br J Pharmacol 1991;103:1067-1072.
9. 4-like receptor in human right atrium. Naunyn Schmiedebergs Arch Pharmacol 1991;344:150-159.
10. 4 receptor mediating tachycardia in the pig. Br J Pharmacol 1991;102:107-112.
11. 4 receptor agonists facilitate cholinergic transmission in circular muscle of guinea pig ileum: Antagonism bv tropisetron and DAU 6285. Life Sci 1992;50:PL173-PL178.
12. 4 receptor mechanism. J Pharmacol Exp Ther 1993;264:240-248.
13. Tam FSF, Hillier K, Bunce K: Investigation of the 5-HT receptor type involved in inhibition of spontaneous activity of human circular muscle (abstract). Br J Pharmacol 1992;106:25P.
14. 4 receptor subtype. J Med Chem 1992;35:1486-1489.
15. 4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum. J Pharmacol Exp Ther 1992;261:412-419.
16. Kawagishi T, Nishizawa Y, Okuno Y, Sekiya K, Morii H: Effect of cisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy. Am J Gostroenterol 1993;88:933-938.
17. 4 receptor: current status. In, Vanhoutle PM, Saxena PR, Paoletti R, Brunello N, Jackson AS (eds.): Serotonin from Cell Biology to Pharmacology and Therapeutics. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1993:107-117.
18. 4 receptor. Med Res Rev 1993;13:633-062.
19. 4 receptors. Potential therapeutic implications in neurology and psychiatry. CNS Drugs 1994;1:6-15.
20. 4 receptor antagonist, on guinea-pig distal colon. Br J Pharmacol 1994;112:789-794.
21. Dhasmana KM, Zhu YN, Cruz SL, Villalón CM: Gastrointestinal effects of 5-hydroxytryptamine and related drugs. Life Sci 1995;53:1651-1661.
22. Agreus L, Svardsudd K, Nyren O, Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109:671-680.
23. 4 receptor. 1. Design of a new class of agonists and receptor map of the agonist recognition site. J Med Chem 1995;38:2326-2330.
24. 4 receptor. 2. Structure-activity studies of the indole carbazimidamide class of agonists. J Med Chem 1995;38:2331-2338.
25. Pfannkuche H-J, Buhl T, Gamse R, Hoyer D, Mattes H, Buchheit K-H: The properties of a new prokinetically active drug, SDZ, HTF 919. Neurogastroenterol Motil 1995;7:280.
26. 3 receptor antagonists. In, Fozard JR, Saxena PR, (eds.): Serotonin: Molecular Biology, Receptors and Functional Effects. Basel: Birkhäuser, 1991;381-388.
27. 3 receptor antagonist, on gastrointestinal motor function in normal subjects. Naunyn Schmiedebergs Arch Pharmacol 1996;353(suppl R):163.
28. Beringer J: ERTS: Experimentelles Run Time System, Version 2.10. Frankfurt am Main: BeriSoft Corporation, 1991.
29. Hubert M, Guerret M: SDZ HTF 919: Analytical data report (data on file). Basel: Sandoz Pharma Ltd., 1994.
30. Gibaldi M, Perrier D: Pharmacokinetics. Drugs and the Pharmaceutical Sciences. Second Edition. New York, Basel: Marcel Dekker, Inc., 1982.
31. Zar JH: Biostatistical Analysis. Second Edition. Englewood Cliffs: Prentice-Hall International, 1984.
32. Chow S-C, Liu J-P: Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker, Inc., 1993.
33. Chaussade S, Roch H, Khyari A, Couturier D, Guerre J: Mesure du temps de transit colique (TTC): description et validation d'une nouvelle technique. Gastroenterol Clin Biol 1986;10:385-389.
34. Metcalf AM, Philips SF, Zinsmeister AR, MacCarthy RL, Beart RW, Wolff BG: Simplified assessment of segmental colonic transit. Gastroenterology 1987;92:40-47.
35. 4 receptor. Naunyn Schmiedebergs Arch Pharmacol 1992;346:496-503.
36. 4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br J Pharmacol 1995;114:993-998.
37. 4 receptors in the human and guinea pig brain. Neuroreport 1993;4:1239-1242.
38. 4 receptors and gastrointestinal prokinetic action. Pharmacol Res 1991;24:5-14.
39. Kamm MA: The small intestine and colon: Scintigraphic quantitation of motility in health and disease. Eur J Nucl Med 1992;19:902-912.
40. Kenakin TP: The Pharmacological Analysis of Drug Receptor Interaction. New York: Raven Press, 1993.